Veritone, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Dissenting stockholder [Member]	Bridge Loan [Member]	Series B Redeemable Convertible Preferred Stock [Member]	Series A Redeemable Convertible Preferred Stock [Member]	Conversion of Convertible Note Payable [Member]	Common Stock [Member]	Common Stock [Member] Dissenting stockholder [Member]	Common Stock [Member] Bridge Loan [Member]	Common Stock [Member] Series B Redeemable Convertible Preferred Stock [Member]	Common Stock [Member] Series A Redeemable Convertible Preferred Stock [Member]	Common Stock [Member] Conversion of Convertible Note Payable [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Dissenting stockholder [Member]	Additional Paid-in Capital [Member] Bridge Loan [Member]	Additional Paid-in Capital [Member] Series B Redeemable Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member] Series A Redeemable Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member] Conversion of Convertible Note Payable [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance at Dec. 31, 2015	$ (19,578)						$ 2						$ (4,527)						$ (15,053)
Beginning balance, shares at Dec. 31, 2015							1,301,249
Issuance of common stock	159												159
Issuance of common stock, shares							106,420
Exercise of options	77												77
Exercise of options, shares							51,504
Issuance of warrants	458												458
Beneficial conversion feature	1,812												1,812
Stock-based compensation expense	1,730						$ 2						1,728
Stock-based compensation expense, shares							961,835
Restricted stock issued	0						$ 0						0						0	$ 0
Restricted stock issued, shares							199,795
Accretion of redeemable convertible preferred stock	(3,204)																		(3,204)
Net loss	(26,979)																		(26,979)
Ending balance at Dec. 31, 2016	(45,525)						$ 4						(293)						(45,236)
Ending balance, shares at Dec. 31, 2016							2,620,803
Exercise of Primary Warrant	29,263						$ 2						29,261
Conversion of debt and accrued interest			$ 8,045			$ 20,737						$ 1			$ 8,045			$ 20,736
Exercise of Primary Warrant, shares							2,150,335
Conversion of debt and accrued interest, shares			590,717						590,717			1,523,746
Issuance of restricted stock, net of forfeitures	(33)												(33)
Issuance of restricted stock, net of forfeitures, shares							22,963
Issuance of common stock		$ 56,342	$ 3,666					$ 4						$ 56,338	$ 3,666
Buy-back/Repurchase of common stock	$ (56)												(56)
Issuance of common stock, shares	13,538,080							3,621,250	300,000
Buy-back/Repurchase of common stock, shares	(7,500)						(7,500)
Conversion of preferred stock				$ 18,668	$ 8,598					$ 2	$ 3					$ 18,666	$ 8,595
Conversion of preferred stock, shares				2,309,135	2,922,798					2,309,135	2,922,798
Exercise of options	$ 131												131
Exercise of options, shares							80,829
Issuance of warrants	8,658												8,658
Beneficial conversion feature	554												554
Modification of warrants	371												371
Stock-based compensation expense	16,089												16,089
Stock-based compensation expense, shares							23,807
Accretion of redeemable convertible preferred stock	(4,470)																		(4,470)
Net loss	(59,601)																		(59,601)
Other comprehensive loss	(135)																			(135)
Ending balance at Dec. 31, 2017	$ 61,302						$ 16						$ 170,728						$ (109,307)	$ (135)
Ending balance, shares at Dec. 31, 2017							16,158,883